Exciva is a clinical stage biopharmaceutical company focused on delivering an innovative treatment to address symptoms of Alzheimer’s patients.
Total raised: $10.46M
Investors 2
| Date | Name | Website |
| 15.11.2021 | LBBW Ventu... | lbbwvc.de |
| - | Andera Par... | anderapart... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.10.2021 | Series A | $10.46M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 03.05.2022 | Andera Partners supports Tubulis in a €60 million Series B f... | Andera Partners, a leading European private equity player, through its biotech and medtech practice ... | anderapart... |
| 27.10.2021 | German biotech startup Exciva secures €9M to address ‘Agitat... | Germany-based Exciva, a clinical-stage biotech company developing a novel therapeutic compound for t... | siliconcan... |
| 27.10.2021 | Biotech startup Exciva scores €9M Series A | Germany-based Exciva has raised €9 million in a round led by Andera Partners. The startup is develop... | pitchbook.... |
| 26.10.2021 | Exciva Raises €9M in Series A Funding | Exciva GmbH, a Heidelberg, Germany-based clinical biotech company developing a novel therapeutic com... | finsmes.co... |